Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome

Gut

Volumn 53, Issue 10, 2004, Pages 1516-1519

  Saadoun, D ^a   Cazals Hatem, D ^b   Denninger, M H ^b   Boudaoud, L ^b   Pham, B N ^b   Mallet, V ^a   Condat, B ^a   Briere J ^b   Valla, D ^a,b  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOPATHOLOGY; LIVER BIOPSY; LIVER GRANULOMA; LIVER SINUSOID; MALE; ORAL CONTRACEPTION; POLYCYTHEMIA; PRIORITY JOURNAL; THROMBOPHILIA; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; DILATATION, PATHOLOGIC; FEMALE; HUMANS; LIVER; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED;

EID: 4644330164     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.037135     Document Type: Article

References (29)

1. Degott C, Potet F. Peliosis hepatitis and sinusoidal dilatation. Arch Anat Cytol Pathol 1984;32:296-300.
2. Bruguera M, Aranguibel F, Ros E, et al. Incidence and clinical significance of sinusoidal dilatation in liver biopsies. Gastroenterology 1978;75:474-8.
3. Capron JP, Lemay JL, Gontier MF, et al. Hepatic sinusoidal dilatation in Crohn's disease. Scand J Gastroenterol 1979;14:987-92.
4. Laffon A, Moreno A, Gutierrez-Bucero A, et al. Hepatic sinusoidal dilatation in rheumatoid arthritis. J Clin Gastoenterol 1989;11:653-7.
5. Aoyagi T, Mori I, Ueyama Y, et al. Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma. Hum Pathol 1989;20:1193-7.
6. Bruguera M, Caballero T, Carreras E, et al. Hepatic sinusoidal dilatation in Hodgkin's disease. Liver 1987;7:76-80.
7. Balazs M. Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases. Exp Pathol 1988;35:231-7.
8. Scoazec JY, Marche C, Girard PM, et al. Peliosis hepatis and sinusoidal dilatation during infection by the human immunodeficiency virus (HIV). An ultrastructural study. Am J Pathol 1988;131:38-47.
9. Bilodeau M, Aubry MC, Houle R, et al. Evaluation of hepatocyte injury following partial ligation of the left portal vein. J Hepatol 1999;30:29-37.
10. Ludwig J, Hashimoto E, Obata H, et al. Idiopathic portal hypertension. Hepatology 1993;17:1157-62.
11. Hillaire S, Bonte E, Deninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a reevaluation in 28 patients. Gut 2002;51:275-80.
12. Zafrani ES, Pinaudeau Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch Intern Med 1983;143:495-502.
13. Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis 2001;21:337-49.
14. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002;37:527.
15. Rosner E, Pauzner R, Lusky A, et al. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144-8.
16. Bertina RM, Koeleman RPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
17. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
18. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
19. Berlin NI. Classification of the polycythemias and initial clinical features in polycythemia vera. In: Wasserman LR, Berk PD, Berlin NI, eds. Polycythemia vera and the myeloproliferative disorders. Philadelphia: WB Saunders Company, 1995:22-30.
20. Schubert J, Alvarado M, Uciechowski P, et al. Diagnosis of paroxysmal nocturnal hemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 1991;79:487-91.
21. Nouchi T, Tanaka Y, Tsukada T, et al. Appearance of alpha-smooth-actin- positive cells in hepatic fibrosis. Liver 1991;11:100-5.
22. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
23. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors. Hepatology 2000;31:587-91.
24. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:145-51.
25. Wahl DG, Guillemin F, de Maistre E, et al. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998;7:15-22.
26. Burcoglu-O'ral A, Erkan D, Asherson RA. Treatment of catastrophic antiphospholipid syndrome (CAPS) with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol 2002;29:2006-11.
27. Meroni PL, Raschi E, Testoni C, et al. Statins prevent endothelial cell activation induced by antiphospholipid antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001;44:2870-8.
28. Roubey RAS. New approachs to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials and tribulations. Arthritis Rheum 2003;41:3004-8.
29. Perez-Ruiz F, Zea-Mendoza AC. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies. J Clin Gastroenterol 1998;27:90-1.